Research

Scientists have developed a new machine-learning model to predict microbial load — the density of microbes in our guts — and used it to demonstrate how microbial load plays an important role in disease-microbiome associations Summary In sickness or in health, the billions of microorganisms that inhabit our guts are our constant companions throughout life. […]

Cyberattacks and analog attacks are a serious and ever-increasing threat to hospitals. In 2022, the Dr. Nope campaign at the four university hospitals in Baden-Württemberg demonstrated in a humorous way how employees can protect information and IT tools through their own personal behavior. The information security initiative has now been awarded the Security Prize at […]

Chicago, IL – November 14, 2024 — VectorBuilder, a global leader in gene delivery solutions, proudly announces that its chief scientist, Dr. Bruce Lahn, has been recognized on the 2024 Forbes China 100 Most Influential Chinese list. This distinguished annual selection honors 100 prominent Chinese figures shaping business, culture, and philanthropy globally, with past recipients including NVIDIA’s Jenson […]

Caries, periodontitis and tooth loss cost billions of dollars worldwide every year. This is the result of a recent study at Heidelberg University Hospital and the Medical Faculty Heidelberg of Heidelberg University. Treatment costs for oral, dental and jaw diseases rank third in the EU, behind cardiovascular diseases and diabetes. The results of the study […]

Heidelberg, Germany, November 6, 2024 – The technology transfer platform InnovationLab is looking forward to the premiere of a new event format: hydrogen experts from Germany and abroad are expected to attend the Clean Tech Innovation Day on Monday, November 11 (9 a.m. to 6 p.m.). Together with its two co-partners, the Rhine-Neckar metropolitan region […]

An international research team led by Professor Dr. Lucas Schirmer and Professor Dr. Julio Saez-Rodriguez from the Medical Faculties of Heidelberg University, in Mannheim and Heidelberg, has studied the different cell types in so-called subcortical lesions, tissue damage to deep brain structures, at different stages of multiple sclerosis (MS) and investigated how they communicate. In […]

Partnership to Combine AbbVie’s Oncology Expertise with EvolveImmune’s Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer NORTH CHICAGO, Ill. and BRANFORD, Conn., Oct. 31, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) and EvolveImmune Therapeutics, an immuno-oncology company developing next-generation biotherapeutics to overcome the therapeutic challenges of cancer cell resistance to current immunotherapies, today announced a collaboration […]

Prestigious funding by the European Research Council for innovative biomedical project Heidelberg scientist Dr Venera Weinhardt has received an ERC Synergy Grant for a pioneering biomedical research project in collaboration with teams in Ireland and the United Kingdom. The European Research Council (ERC) is granting this highly endowed funding to advance soft X-ray microscopy. This […]

While previous IHI calls defined the challenges applicants should address, call 9 will invite applicants to identify untapped opportunities in the IHI Strategic Research and Innovation Agenda. Key dates and links 10 October: Online info session on the call and the brokerage platform and event – register here Mid October: Publication of the draft call text on our Future […]